Castellani P, Meinardi G, Della Bruna C
Farmitalia Carlo Erba, Research and Development, Milan, Italy.
J Antimicrob Chemother. 1989 Mar;23 Suppl C:157-63. doi: 10.1093/jac/23.suppl_c.157.
The therapeutic activities of the parenterally administered penem FCE 22101, cefuroxime and ampicillin were compared in an experimental model of genital infections in progesterone-treated virgin rats and normal female mice. Treatment with FCE 22101 significantly inhibited the proliferation of Staphylococcus aureus ATCC 13709, Escherichia coli G and Enterobacter cloacae 1321 E, as compared with untreated controls. Against Staph. aureus ampicillin was slightly more active than cefuroxime, which showed equivalent activity to FCE 22101, while against Esch. coli and Ent. cloacae cefuroxime and ampicillin were less active than FCE 22101. The activity of the antibiotics against beta-lactamase-producing strains was also tested and here FCE 22101 exhibited the greatest inhibitory effect on bacterial growth.
在经孕酮处理的未交配大鼠和正常雌性小鼠的生殖器感染实验模型中,比较了肠胃外给药的青霉烯类药物FCE 22101、头孢呋辛和氨苄西林的治疗活性。与未治疗的对照组相比,FCE 22101治疗显著抑制了金黄色葡萄球菌ATCC 13709、大肠杆菌G和阴沟肠杆菌1321 E的增殖。针对金黄色葡萄球菌,氨苄西林的活性略高于头孢呋辛,头孢呋辛与FCE 22101活性相当,而针对大肠杆菌和阴沟肠杆菌,头孢呋辛和氨苄西林的活性低于FCE 22101。还测试了这些抗生素对产β-内酰胺酶菌株的活性,在此FCE 22101对细菌生长表现出最大的抑制作用。